Accuracy of Positioning Guide and Customized Plate in Zygomaticomaxillary Complex Fractures
1 other identifier
interventional
8
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate the accuracy and stability of positioning guides and customized titanium plates in the treatment of Zygomaticomaxillary Complex (ZMC) fractures. The main questions it aims to answer are:
- Is the anatomical reduction achieved using a virtual planning-based positioning guide accurate when compared to preoperative plans?
- Does the customized titanium plate provide stable fixation during the follow-up period? Researchers will compare the actual postoperative outcome to the preoperative virtual surgical plan to see if the customized workflow improves anatomical alignment. Participants will:
- Undergo a preoperative Computed Tomography (CT) scan for virtual surgical planning.
- Receive surgical treatment using a patient-specific positioning guide and customized titanium plate.
- Complete follow-up assessments including postoperative CT scans and clinical evaluations for 6 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
May 27, 2026
May 1, 2026
1.1 years
April 29, 2026
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Accuracy of Fracture Reduction
Evaluation of the accuracy of fracture reduction achieved using the positioning guide and customized titanium plate. This will be assessed by superimposing the post-operative computed tomography (CT) scans onto the pre-operative virtual surgical plan. The difference will be reported as linear deviation, measured in millimeters (mm).
one week postoperative
Assessment of Facial Symmetry (Malar Projection)
Evaluation of aesthetic outcome and facial symmetry by assessing the malar projection. This will be measured clinically or via imaging (e.g., comparing the fractured side to the intact side). The outcome will be reported as the linear discrepancy or difference between the two sides, measured in millimeters (mm).
6 months postoperatively
Secondary Outcomes (3)
Assessment of Ocular Motility and Diplopia
6 months postoperatively
Total Operative Time
Day of surgery (Intraoperative)
Patient Satisfaction
6 months postoperatively
Study Arms (1)
Virtual Planning and Customized Plates
EXPERIMENTALPatients with ZMC fractures undergoing surgical treatment using 3D virtual planning and patient-specific titanium plates.
Interventions
A 3D-printed positioning guide designed through virtual surgical planning to assist in the accurate reduction of ZMC fractures.
A custom-fabricated titanium plate designed to fit the patient's specific anatomy for rigid fixation of ZMC fractures.
Eligibility Criteria
You may qualify if:
- Patients diagnosed with Zygomatico-maxillary complex fractures requiring surgical intervention.
- Patients aged 18 years or older.
- Patients willing to provide informed consent and comply with follow-up protocols.
- Patients with adequate bone quality and quantity for stable fixation.
You may not qualify if:
- Patients with comminuted ZMC fractures that preclude the use of custom-made guides based on mirroring the contra lateral side.
- Patients with pre-existing facial deformities or asymmetries that would interfere with accurate assessment of fracture reduction.
- Patients with systemic diseases or conditions that contraindicate elective surgery or impair bone healing (e.g., uncontrolled diabetes, severe osteoporosis, active malignancy, and immunosuppression).
- Patients on medications affecting bone metabolism (e.g., long-term corticosteroids, bisphosphonates). Patients with active infections in the maxillofacial region.
- Pregnant or lactating women.
- Patients with psychiatric disorders or unrealistic expectations.
- Patients who are unable to undergo CT scans or follow post-operative instructions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
department of oral and maxillofacial surgery, faculty of dentistry, Cairo university
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Prof. Ramy Ragab Elbialy, prof. of maxillofacial surgery
Department of Oral and maxillofacial surgery,Faculty of dentistry, Cairo university
- STUDY DIRECTOR
Dr. Mohamed Ali Zain Elabden, lecturer of maxillofacial surg
Department of Oral and maxillofacial surgery, Faculty of dentistry, Cairo university
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 29, 2026
First Posted
May 27, 2026
Study Start
November 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
September 1, 2027
Last Updated
May 27, 2026
Record last verified: 2026-05